102
Participants
Start Date
September 30, 2024
Primary Completion Date
December 30, 2025
Study Completion Date
December 30, 2025
Eptinezumab
The study treatment consists of a single infusion of eptinezumab (100mg/mL).
Standard of Care
SoC may include a combination of Toradol, Metoclopramide, and/or Benadryl. Ketamine and/or Midazolam may also be used, according to a stepwise approach, at the discretion of the treating physician. The timing and dose of all medication(s) administered in the ED will be recorded.
Royal Columbian Hospital, New Westminster
Surrey Memorial Hospital, Surrey
H. Lundbeck A/S
INDUSTRY
Centre for Neurology Studies, Surrey Neuroplasticity Clinic Inc.
UNKNOWN
Royal Columbian Hospital Foundation
OTHER
Surrey Memorial Hospital
UNKNOWN
Dr George Medvedev
INDUSTRY